A unique peer-reviewed publication linking primary and secondary cardiovascular care.
Explore contentFeatured articles
Diabetes Distilled: Cagrilintide/semaglutide in type 2 diabetes – REIMAGINE the impactIn the REIMAGINE series of clinical trials, cagrilintide, a long-acting amylin agonist, when combined with semaglutide, at doses of 2.4 mg/2.4 mg or 1 mg/1 mg, in people with type 2 diabetes, demonstrated greater reductions i...
Featured articles
GLP-1 receptor agonists in cardiovascular disease: a guide for cardiologistsObesity is a global epidemic, which, directly and indirectly, contributes to almost all cardiovascular diseases, including atherosclerotic cardiovascular disease, heart failure and atrial fibrillation. Reduction of weight is associated with substanti...
Featured articles
Interactive case study: Add-on medication for type 2 diabetesThese four scenarios review the add-on therapies recommended in the NICE NG28 guideline when initial therapies for type 2 diabetes do not achieve HbA1c targets. Access the case study here.
- Sponsored -
BJC TV offers short, engaging videos from cardiology experts in primary and secondary care, providing practical advice to help busy clinicians stay up to date.
No articles matched your search.
In Association With:
A unique peer-reviewed publication linking primary and secondary cardiovascular care.
Explore content
Primary care insights and practical resources for diabetes management.
Explore content
Nursing-focused diabetes content, case studies and expert commentary.
Explore content
Focused coverage of nephrology practice, trials and treatment updates.
Explore content